2014
DOI: 10.1016/j.ejmg.2013.12.005
|View full text |Cite
|
Sign up to set email alerts
|

A prenatal case of split-hand malformation associated with 17p13.3 triplication – A dilemma in genetic counseling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
16
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 11 publications
(17 citation statements)
references
References 7 publications
0
16
1
Order By: Relevance
“…This study demonstrates the limitation of clinical microarrays (NimbleGen CGX‐135K array, average resolution of 140 kb across the genome and 40 kb or less in regions of clinical relevance [Luk et al., ]) in differentiating higher‐order copy‐number changes, such as triplications and quadruplications. Higher copy‐number changes (comparing triplication to duplication) are known to be associated with more severe phenotypes for certain dosage‐sensitive genes, including YWHAE and BHLHA9 [Fuchs et al., ; Bi et al., ; Liu et al., ; Nagata et al., ].…”
mentioning
confidence: 90%
See 2 more Smart Citations
“…This study demonstrates the limitation of clinical microarrays (NimbleGen CGX‐135K array, average resolution of 140 kb across the genome and 40 kb or less in regions of clinical relevance [Luk et al., ]) in differentiating higher‐order copy‐number changes, such as triplications and quadruplications. Higher copy‐number changes (comparing triplication to duplication) are known to be associated with more severe phenotypes for certain dosage‐sensitive genes, including YWHAE and BHLHA9 [Fuchs et al., ; Bi et al., ; Liu et al., ; Nagata et al., ].…”
mentioning
confidence: 90%
“…Previously, we reported a prenatal case (BAB7218) with split‐hand malformation detected by fetal ultrasound [Luk et al., ]. Clinical microarray (NimbleGen CGX‐135K array) showed two maternally inherited triplications separated by a copy‐number neutral region at 17p13.3 in the fetus.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Most countries and major societies already endorsed the use of CMA in place of karyotyping for prenatal diagnosis (Armour et al, ; Committee on Genetics & the Society for Maternal‐Fetal Medicine, ; Malan et al, ; RANZCOG, ; Vanakker et al, ). CMA has been commonly accepted as part of prenatal diagnosis in the last several years in Hong Kong not only to improve the prenatal care (Cheng, Kan, Hui, Lee, & Tang, ; Kan & Chan, ), but also to understand the underlying causes of the fetal abnormalities (Au et al, ; Cheung et al, ; Hui et al, ; Lau et al, ; Leung et al, ; Luk et al, ). This would not be achieved by conventional cytogenetics although CMA remained a self‐financed test.…”
Section: Introductionmentioning
confidence: 99%
“…A multicentre study in UK on array comparative genomic hybridisation in prenatal diagnosis of fetal anomalies concluded that CMA was a robust, acceptable, and probably cost-effective method to detect more clinically significant chromosomal imbalances in anomalous fetuses 17 . In Hong Kong, CMA has been accepted as a part of prenatal diagnosis to improve the prenatal care [18][19][20][21] and to investigate the underlying causes of fetal abnormalities 7,[22][23][24][25][26][27][28][29][30][31][32][33] that cannot be achieved by conventional cytogenetics alone.…”
Section: Prenatal Diagnosis Workflow With Cmamentioning
confidence: 99%